ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0750

Nuclei Detection in Rheumatoid Arthritis Synovial Tissue Using Artificial Intelligence

Steven Guan1, David Slater1, James Thompson1, Edward DiCarlo2, Diyu Pearce-Fisher2, Susan Goodman3, Bella Mehta4 and Dana Orange5, 1MITRE, McLean, VA, 2Hospital for Special Surgery, New York, 3Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 4Hospital for Special Surgery/Weill Cornell Medicine, New York, NY, 5Rockefeller University, New York

Meeting: ACR Convergence 2020

Keywords: Decision analysis, Imaging, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 7, 2020

Title: RA – Diagnosis, Manifestations, & Outcomes Poster II: Biomarkers

Session Type: Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Hematoxylin and eosin (H&E) stained rheumatoid arthritis synovium are routinely used to assess inflammation [1]. In this work, we propose an automated approach using artificial intelligence (AI) to quantify all cell nuclei in whole slide H&E stained images. This approach provides quantitative information on the number and density of nuclei in synovial images. Given nuclei density is generally increased in sites of inflammation, this approach can identify areas of interest for further evaluation [2].

Methods: The proposed AI algorithm was used to segment cell nuclei in H&E-stained images. First, we split the whole slide image into 1024×1024 tiles with a resolution of 50 μm. Each tile was then processed as follows: 1) separate stained components using color deconvolution, 2) binarize image using local adaptive thresholding, 3) split clustered nuclei using the watershed algorithm, and 4) remove false-positive detected nuclei using shape analysis. Finally, the total nuclei count normalized for area of tissue and the nuclei density were calculated. In total, 166 H&E stained images were analyzed, and corresponding synovial tissue samples were classified by pathologist score of lymphocytic inflammation (0-4). Of which, 35 samples were also classified by RNA sequencing gene expression cluster (low, mixed, and high inflammatory gene expression) as previously described [1]. A one-way ANOVA test and post-hoc analysis using the Tukey’s test corrected for multiple comparisons were conducted.

Results: Upon visual inspection, the algorithm identified majority of the nuclei in a tile, as seen in Figure 1. There was a statistically significant difference in the mean nuclei count and nuclei density between the gene expression subtypes (p=0.01, p=0.03) as well as pathologist scores of lymphocytic infiltration (p< 0.01, p< 0.01), as seen in Table 1 and Figure 2. The post-hoc analysis revealed that the mean normalized nuclei count and nuclei density was significantly different between the mixed and high-inflammatory subtypes (p=0.01, p=0.03) and between the lowest and highest lymphocyte pathologist scores (p< 0.01, p< 0.01).

Conclusion: Automated image quantification of H&E stained nuclei suggests that nuclei count and density are increased in synovial samples with high inflammatory gene expression and high pathology scores of synovial lymphocytic inflammation. Additional algorithm validation is needed to better understand its limitations. This approach provides a quantitative framework to score stained images and identify abnormal or inflamed areas. Future efforts will attempt to identify other histological features which might be clinically useful for assessing RA synovium.

Figure 1. Nuclei identified using the proposed AI algorithm and visualized with boundaries and masks for tiles with mild (a-b) and band-like (c-d) lymphocytic inflammation.

Table 1. RA cohort description of nuclei count and density by RNA subtypes and pathologist lymphocytic inflammation scores.

Figure 2. Boxplots to visualize distribution of nuclei count and density by RNA subtypes (low, mixed, and high inflammatory) (a-b) and lymphocytic inflammation scored by pathologist (c-d).


Disclosure: S. Guan, None; D. Slater, None; J. Thompson, None; E. DiCarlo, None; D. Pearce-Fisher, None; S. Goodman, Pfizer, 1, Novartis, 1, UCB, 1, regenosine, 1, 2, Horizon, 1; B. Mehta, None; D. Orange, None.

To cite this abstract in AMA style:

Guan S, Slater D, Thompson J, DiCarlo E, Pearce-Fisher D, Goodman S, Mehta B, Orange D. Nuclei Detection in Rheumatoid Arthritis Synovial Tissue Using Artificial Intelligence [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/nuclei-detection-in-rheumatoid-arthritis-synovial-tissue-using-artificial-intelligence/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nuclei-detection-in-rheumatoid-arthritis-synovial-tissue-using-artificial-intelligence/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology